| 000 | 00992 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516025739.0 | ||
| 264 | 0 | _c20160422 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1752-8526 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcManus, Richard J | |
| 245 | 0 | 0 |
_aThromboembolism. _h[electronic resource] |
| 260 |
_bBMJ clinical evidence _cMar 2011 |
||
| 500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPulmonary Embolism _xchemically induced |
| 650 | 0 | 4 |
_aThromboembolism _xchemically induced |
| 650 | 0 | 4 |
_aVenous Thrombosis _xchemically induced |
| 650 | 0 | 4 |
_aWarfarin _xtherapeutic use |
| 700 | 1 | _aFitzmaurice, David A | |
| 700 | 1 | _aMurray, Ellen | |
| 700 | 1 | _aTaylor, Clare | |
| 773 | 0 |
_tBMJ clinical evidence _gvol. 2011 |
|
| 999 |
_c20657955 _d20657955 |
||